Autoimmunity Reviews

Article	Citations
Editorial Board	287
Editorial Board	183
“Fibromyalgia syndrome” related to Essure devices	153
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	117
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	110
Editorial Board	105
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	97
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	90
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	86
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	80
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	79
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	76
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	75
Endometriosis and autoimmunity	75
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	74
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	72
Susac syndrome: A scoping review	71
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	70
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	69
Editorial Board	69
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	69
Can anticoagulation be withdrawn in APS patients after aPL negativization?	66
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	65
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	60
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	60

The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	59
Seronegative autoimmune diseases: A challenging diagnosis	59
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	58
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	51
Autoimmune pre-disease	51
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	50
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	50
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	49
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	49
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	49
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	48
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	46
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	44
Autoimmunity in vitiligo: Therapeutic implications and opportunities	43
Psychiatric manifestations of autoimmune encephalitis	42
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	42
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	42
Cardiovascular outcome in adult-onset Kawasaki disease	42
Editorial Board	41
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	41
A descriptive study of IgG4-related disease in children and young adults	41
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	41
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	40
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	40
SpA plus IBD or IBD plus SpA: Does commutative property apply?	39
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	38
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	38
Adipose failure through adipocyte overload and autoimmunity	37
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	37
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	37
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	36
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	36
Editorial Board	35
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	35
Editorial Board	34
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	34
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	34
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	33
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	33
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	33
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	33
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	32
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	32
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	32
Fibromyalgia: Are we using the biopsychosocial model?	32
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	32
Development of an algorithm for IgG4-related disease management	31
Tumor necrosis factor-α inhibitor-related autoimmune disorders	31
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	30
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	30

Chronic inflammation in Long COVID relationship to autoimmune diseases	30
The role of mitochondrial dysfunction in kidney injury and disease	30
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	30
Editorial Board	29
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	29
Are IF-ANA the guiding light for SLE classification in the real-world setting?	29
Reply letter to letter to the editor	29
Anti-rods/rings autoantibodies in a patient with pancreatic injury	28
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	28
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	27
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	27
Editorial Board	27
Editorial Board	27
Twenty shades of the mosaic of autoimmunity	27
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	27
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	26
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	26
Tumors, tumor therapies, autoimmunity and the eye	26
Alarmins in autoimmune diseases	26
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	26
Mucous membrane pemphigoid	26
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	25
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	25
Rheumatological complications of Covid 19	25
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	25
In Memoriam: Pierre Youinou	25
Neuroimaging in thyroid eye disease: A systematic review	25
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	24
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	24
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	24
Cutting edge confusion about cut-off settings in autoimmune diagnostics	24
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	23
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	23
Is it time for treat-to-target in antiphospholipid syndrome?	23
Editorial Board	23
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	23
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	23
Serum calprotectin is a marker of disease activity in Giant cell arteritis	23
Diagnostic approach in giant cell arteritis	23
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	22
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	21
From inflammation to renal fibrosis: A one-way road in autoimmunity?	21
Salivary gland involvement in ANCA-associated vasculitis	21
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	21
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	21
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	21
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	21
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	20
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	20
Inflammatory muscle involvement in systemic vasculitis: A systematic review	20
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	20
Editorial Board	20
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	20
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	20
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	20
JAK inhibitors and systemic sclerosis: A systematic review of the literature	20
Persistent aortic inflammation in patients with giant cell arteritis	20
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	19
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	19
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	19
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	19
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	19
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	19
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?	19
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	19
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	19
Don't mix apples and oranges. Reply to Azoulay et al.	19
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	18
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	18
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	18
Intermittent fasting: A promising dietary intervention for autoimmune diseases	18
Editorial Board	18
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	17
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	17
Anti-glomerular basement membrane vasculitis	17
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	17
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	17
Prevention of rheumatoid arthritis using a familial predictive medicine approach	17
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	17
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	17

Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	17
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	17
Involvement of aquaporin 5 in Sjögren’s syndrome	16
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	16
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	16
Editorial Board	16
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	16
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	16
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	16
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations	16
Emerging roles of mechanically activated ion channels in autoimmune disease	16
Insights into new-onset autoimmune diseases after COVID-19 vaccination	16
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	16
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	16
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	16